-
Asian Games set to close after records, rancour and rain
-
Chanel: unpicking one year of 'Blazymania'
-
Cry for help as French-Swiss lake dries up
-
Latvian pro-Europeans set for election win: partial results
-
Sabalenka swept out of China Open in third round
-
China swim sensation Yu Zidi, 13, says 'I'm no prodigy'
-
US urges 'restraint' as Ethiopia's Tigray crisis rocks region
-
Yu Zidi to Ohashi: Asian Games stars who can light up LA Olympics
-
Teens on target again as USA down Mexico 3-0
-
'Act before it's too late': Tokyo residents fight for more trees
-
World records prove Asian Games were a hit, says top official
-
'Disappointing' as South Korea flag mishap sees Games end on sour note
-
US prison chief who oversaw botched execution resigns
-
Pre-COP host Tuvalu at frontline of climate change
-
'Chaotic' Asian Games threaten Japan hopes of hosting Olympics again
-
Hungary's dwindling paprika producers battle to save signature spice
-
Finnish town braces for change from Google data centres
-
Cornell president vows review in wake of alleged student gang rape
-
What is fuelling French school protests?
-
Latvian partial election results suggest pro-European choice
-
Without lawyers, migrant children face deportation from the US
-
In Egypt's Sinai, Gazan builds school for children displaced by war
-
Three-peat seeking Dodgers open playoffs with a win, Rays hold off Yankees
-
Trump tariffs a mixed bag for US auto industry
-
Brazil votes in nail-biter polls closely watched by Trump
-
Yemen government forces say struck Houthi targets
-
'Just be you': Kim reveals Tiger text that inspired him to gold
-
Music links past, present for Pedro Pascal's cellist in 'Behemoth!'
-
Myanmar migrants returned to war-torn nation from Malaysia
-
ALEX BODI ȘI AMBASADORUL REPUBLICII SUDANUL DE SUD, GUM DOMINIC MATIOK, DISCUTĂ LA BERLIN DESPRE POSIBILITATEA ÎNFIINȚĂRII UNUI CONSULAT ONORIFIC LA BUCUREȘTI
-
ALEX BODI AND AMBASSADOR GUM DOMINIC MATIOK OF THE REPUBLIC OF SOUTH SUDAN MEET IN BERLIN TO DISCUSS THE POSSIBILITY OF AN HONORARY CONSULATE IN BUCHAREST
-
Dodgers step up World Series three-peat bid with 5-3 win over Braves
-
Lula, Bolsonaro wrap up campaigns ahead of Brazil's knife-edge vote
-
Spain break down Czechs as England outclass Croatia in Nations League
-
Toulouse edge Castres in Top 14 derby
-
Yamal on target as Spain hold off Czech Republic
-
Murakami homer propels White Sox to MLB playoff win over Guardians
-
Latvian exit polls suggest pro-European choice
-
Israel targets top Hamas leader in deadly Gaza strike on anniversary
-
Lula, Bolsonaro wrap up campaigns ahead of knife-edge election
-
Houthis say struck oil facility near Riyadh, as Saudis hit Sanaa
-
Tuchel hails 'complete' England after Croatia demolition
-
AI needs safety layers like nuclear plants: ex-OpenAI engineer
-
Fury to invite Trump to lead ring walk before Joshua showdown
-
MVP Judge will miss Yankees' MLB playoff series against Rays
-
Fashion industry in 'precarious moment', says Vivienne Westwood supremo
-
New lizard species discovered in Peru
-
Seventh heaven for England in Nations League rout of Croatia
-
Fernandes hails Portugal's 'greatest symbol' Ronaldo, calls for unity
-
Storms, flooding cause chaos on Greek holiday island of Crete
First person vaccinated during trial of new Ebola jab
A volunteer was injected on Friday with the first dose of a rapidly developed vaccine targeting the Bundibugyo strain of Ebola driving a deadly outbreak in the Democratic Republic of Congo, Oxford University said.
More than 1,000 people have been killed in the DRC and Uganda since the outbreak emerged in May, according to the World Health Organization.
Researchers and health organisations have since been racing to get a vaccine or treatment for the relatively rare strain to the clinical trial stage where it is tested on humans.
Earlier this month, a team at Oxford University in the UK announced it was launching the first trial for its ChAdOx1 BDBV vaccine, which uses the same technology as AstraZeneca's Covid-19 vaccine.
The first dose was administered to a 37-year-old volunteer named Ed Hunt in Oxford on Friday, a university spokesman told AFP.
"We've taken this vaccine candidate from concept to clinic in just eight weeks," David Pulido-Gomez of Oxford's Pandemic Sciences Institute said in a statement.
"Reaching this milestone in such a short timeframe reflects an extraordinary collaborative effort," he added.
The trial received funding from the Coalition for Epidemic Preparedness Innovations (CEPI), while the Serum Institute of India has already manufactured a stockpile of 620,000 doses.
The phase 1 trial plans to assess the safety and effectiveness of the vaccine in 50 health adults in the coming weeks. The researchers are currently recruiting more volunteers.
Given regulatory approval, the team is preparing for more clinical studies of the vaccine with partners in Uganda, Oxford said.
Several other Bundibugyo vaccine candidates are also being urgently developed towards the trial stage, while two potential treatments are being worked on.
The Ebola outbreak is the 17th in the DRC's history, but just the third caused by the Bundibugyo strain, for which there are no approved vaccines or treatments.
WHO chief Tedros Adhanom Ghebreyesus warned last week that the outbreak had over the past month "expanded faster than any previous outbreak" of Ebola.
The outbreak has remained concentrated in the vast country's mineral-rich and conflict-plagued northeastern province.
Cases of Ebola, which spreads through close contact and infected bodily fluids, have also been found in four other DRC provinces.
H.E.Young--AMWN